Methylation was not observed in any of the primary breast tumor specimens analysed, independently of FBXW7/hCDC4-α mRNA levels, indicating that p53 mutational status is major decisive factor in the regulation of FBXW7/hCDC4-α expression in breast cancer (manuscript in preparation). The gene discussed is TP53; the disease is breast carcinoma.